Scandinavian Journal of Pain
Volume 3, Issue 1 , Pages 5-13 , January 2012

Chronic non-cancer pain and the long-term efficacy and safety of opioids: Some blind men and an elephant?

Received 26 August 2011 ,Revised 12 October 2011 ,Accepted 1 November 2011.

References 

  1. Ballantyne J. Pain medicine: repairing a fractured dream. Anesthesiology. 2011;114:243–246
  2. Sjogren P. Epidemiology of pain and critical issues in opioid use. Pain. 2011;152:1219–1220
  3. Eriksen J, Jensen MK, Sjogren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain. 2003;106:221–228
  4. Sjogren P, Ekholm O, Peuckmann V, Groenbaek M. Epidemiology of chronic pain in Denmark: an update. Eur J Pain. 2009;13:287–292
  5. Toblin RL, Mack KA, Perveen G, Paulozzi LJ. A population based survey of chronic pain and its treatment with prescription drugs. Pain. 2011;1152:1249–1255
  6. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280:147–151
  7. Joransen DE. Improving availability of opioid pain medications; testing the principle of balance in Latin America. J Palliat Med. 2004;7:105–114
  8. Claussen TG, Eriksen J, Borgbjerg FM. Legal opioid consumption in Denmark in 1981–1993. Eur J Clin Pharmacol. 1995;48:321–325
  9. Dhalla IA, Mamdani MM, Silviotti MLA, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181:891–896
  10. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363:1981–1985
  11. Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM. Trends in opioid use and dosing among socio-economically disadvantaged patients. Arch Int Med. 2011;171:686–691
  12. Watson CPN, Babul N. Oxycodone relieves neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837–1841
  13. Harati Y, Gooch C, Swensen M, Edelman S, Greene D, Raskin P, et al. Double blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842–1846
  14. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen R, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy; a randomized, double-blind, controlled trial. Pain. 1999;83:85–90
  15. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;349:1223–1232
  16. Raja SJ, Haythornethwaite JA, Papagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia; a placebo-controlled study. Pain. 2002;94:215–224
  17. Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71–77
  18. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60:927–934
  19. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003;104:323–331
  20. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin or their combination for neuropathic pain. N Engl J Med. 2005;352:1324–1334
  21. Jaffe J. Opiates: clinical aspects. In:  Lowinson JH,  Ruiz P,  Millman RG editor. Substance abuse. A comprehensive textbook. Baltimore: Williams and Wilkins; 1992 p;p. 186–194
  22. Sees KL, Clark KW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage. 1993;8:257–264
  23. Savage SR. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage. 1996;11:274–286
  24. Sacerdote P, Manfredi B, Manttegazza P, Panerai AE. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol. 1997;121:834–840
  25. Sjogren P, Olsen AK, Thomsen AB. Impaired neuropsychological performance in chronic non-malignant pain patients receiving long-term oral therapy. J Pain Symptom Manage. 2000;19:100–108
  26. Mao J. Opioid-induced abnormal pain sensitivity; implications in clinical opioid therapy. Pain. 2002;100:213–217
  27. Rajogopal A, Vassilopoulou-Sellin R, PalmerJL , Kaur G, Brera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to morphine. Cancer. 2004;100:851–858
  28. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression. A review. Am J Ther. 2004;11:354–365
  29. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In:  Kitahata LM,  Collins D editor. Narcotic analgesics in anesthesiology. Baltimore, MD: Williams and Wilkins; 1982;p. 199–208
  30. Portenoy RK, Foley RM. Chronic use of opioid analgesics in non-malignant pain. Report of 38 cases. Pain. 1986;25:171–186
  31. Tennant FS, Robinson D, Sagherian A, Seecof R. Chronic opioid treatment of intractable non-malignant pain. Pain Manage. 1988;18–36
  32. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with nonmalignant pain. J Pain Symptom Manage. 1992;7:69–77
  33. Watson CPN, Watt-Watson J, Chipman ML. Chronic non-cancer pain and the long term utility of opioids. Pain Res Manage. 2004;9:19–24
  34. Watson CPN, Watt-Watson JH, Chipman MA. The long-term efficacy and safety of opioids: a survey of 84 selected patients with intractable chronic non-cancer pain. Pain Res Manage. 2010;15(4):213–218
  35. Becker N, Thomsen AB, Olsen AK, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 2000;73:393–400
  36. Jensen MK, Thomsen AB, Hojsted J. 10 year follow-up of chronic non-malignant pain patients; opioid use, health related quality of life and health care utilization. Eur J Pain. 2006;10:423–433
  37. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues in chronic non-cancer pain: an epidemiological study. Pain. 2006;125:172–179
  38. Daut IE, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197–210
  39. Tait RC, Chibnall JT, Krause S. The Pain Disability Index; psychometric properties. Pain. 1990;40:171–182
  40. Chibnall JT, Tait RC. The Pain Disability Index: factor structure and normative data. Arch Phys Med Rehabil. 1994;75:1082–1086
  41. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370
  42. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  43. Khoromi S, Cui L, Nackers L, Max MB. Morphine versus nortriptyline and their combination in chronic lumbar root pain. Pain. 2007;130:66–75
  44. Chou R, Fanciullo GJ, Fine PG, Adler AM, Ballantyne JC, Davies p , et al. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain. 2009;10:113–130
  45. Butler SF, Fernandez K, Benoit C. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain. 2005;9:345–352
  46. Webster LR, Webster RM. Predicting aberrant behaviour in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6:432–442
  47. Kieburtz K, Simpson D, Yiannoutsios C, Max Mb, Hall CD, Ellis RJ, et al. A randomized trial of amitriptyline and mexiletine in painful neuropathy in HIV infection. Neurology. 1998;51:1682–1688
  48. Mitchell SW. Injuries of nerves and their consequences. JB Lippincott & Co; 1872;p. 270
  49. Furlan AD, Reardon R, Weppler C. Opioids for chronic non-cancer pain: a new Canadian practice guideline. CMAJ. 2010;182(9):923–930

☆ Updated text and illustrations from presentations at the International Neuropathic Pain meeting in Berlin in 2007 and at the Scandinavian Association of Anesthesia and Intensive Care 30th Congress meeting in Odense, Denmark in 2009.

PII: S1877-8860(11)00140-6

doi: 10.1016/j.sjpain.2011.11.001

Scandinavian Journal of Pain
Volume 3, Issue 1 , Pages 5-13 , January 2012

Article Tools

* Image Usage & Resolution